Identification of differentially expressed miRNAs in plasma exosomes from patients with early-onset pre-eclampsia

Wuqian Wang1,2, Weihua Zhang2, Luan Chen1

  • 1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China.

Heliyon
|February 7, 2024
PubMed

Insights

This study identified 65 differentially expressed microRNAs (miRNAs) in the exosomes of early-onset pre-eclampsia (PE) patients. These findings suggest specific miRNAs may serve as biomarkers and play a role in PE pathogenesis.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Pre-eclampsia (PE) is a significant cause of maternal and fetal mortality, with unclear pathogenesis.
  • Identifying molecular markers for early diagnosis and understanding PE development is crucial.

Purpose of the Study:

  • To identify differentially expressed microRNAs (miRNAs) in peripheral blood exosomes of early-onset PE patients.
  • To discover candidate miRNAs as potential molecular markers for PE.

Main Methods:

  • High-throughput sequencing of exosomal miRNAs from five PE patients and five healthy pregnant women.
  • Bioinformatic analysis including target gene prediction, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
  • Quantitative PCR (qPCR) validation of selected miRNAs in an independent cohort.

Main Results:

  • 65 significantly differentially expressed miRNAs were identified (17 up-regulated, 48 down-regulated) in early-onset PE patients.
  • Predicted target genes were enriched in pathways like Ras protein signal transduction, histone modification, TGF-β, PI3K-Akt, and MAPK signaling.
  • Three miRNAs, including MIR7151, were validated, with MIR7151 showing significant differential expression and targeting KCNQ10T1.

Conclusions:

  • Distinct miRNA expression profiles exist in peripheral blood exosomes between early-onset PE patients and healthy controls.
  • These differentially expressed miRNAs are implicated in regulating key biological functions and signaling pathways relevant to PE pathophysiology.
  • Candidate miRNAs, particularly MIR7151, show potential as biomarkers for early-onset PE.